Holen Sie sich die Stockscreener-App
10.81
2.44%
0.2573
Schlusskurs vom Vortag:
$10.55
Offen:
$10.78
24-Stunden-Volumen:
13,199
Relative Volume:
0.31
Marktkapitalisierung:
$43.80M
Einnahmen:
$147.75M
Nettoeinkommen (Verlust:
$-284.23M
KGV:
-3.6885
EPS:
-2.93
Netto-Cashflow:
$-317.54M
1W Leistung:
-4.44%
1M Leistung:
-10.16%
6M Leistung:
+55.95%
1J Leistung:
+20.99%
1-Tages-Spanne:
$10.46
$11.09
1-Wochen-Bereich:
$10.29
$11.55
52-Wochen-Spanne:
$4.50
$21.94
Fibrogen Inc Stock (FGEN) Company Profile
Firmenname
Fibrogen Inc
Sektor
Branche
Telefon
415-978-1200
Adresse
350 BAY STREET, SAN FRANCISCO, CA
Vergleichen Sie FGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FGEN
Fibrogen Inc
|
10.83 | 42.66M | 147.75M | -284.23M | -317.54M | -2.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.13 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-06-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-26 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-06-26 | Herabstufung | Stifel | Buy → Hold |
| 2023-06-26 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-02 | Hochstufung | Stifel | Hold → Buy |
| 2023-01-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-09-22 | Herabstufung | Goldman | Neutral → Sell |
| 2021-08-20 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2021-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-07-16 | Herabstufung | Stifel | Buy → Hold |
| 2021-04-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-04-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-03-31 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-03-02 | Herabstufung | Jefferies | Buy → Hold |
| 2021-02-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-26 | Eingeleitet | Raymond James | Underperform |
| 2020-07-10 | Fortgesetzt | Stifel | Buy |
| 2020-05-01 | Eingeleitet | Cowen | Market Perform |
| 2020-04-27 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-05-29 | Fortgesetzt | Goldman | Neutral |
| 2019-05-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-04-12 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-02-11 | Fortgesetzt | Stifel | Buy |
| 2018-12-19 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-08-08 | Bestätigt | Leerink Partners | Outperform |
| 2017-08-08 | Bestätigt | Stifel | Buy |
| 2017-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2017-07-11 | Eingeleitet | Jefferies | Buy |
| 2016-02-11 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2016-01-21 | Eingeleitet | Credit Suisse | Neutral |
| 2015-12-04 | Eingeleitet | Citigroup | Buy |
| 2015-09-23 | Eingeleitet | Lake Street | Hold |
| 2015-07-29 | Eingeleitet | Citigroup | Buy |
| 2015-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2014-12-09 | Eingeleitet | Stifel | Buy |
Alle ansehen
Fibrogen Inc Aktie (FGEN) Neueste Nachrichten
How FibroGen Inc. (1FG0) stock reacts to monetary easingWatch List & Technical Buy Zone Confirmation - newser.com
Forecasting FibroGen Inc. price range with options dataJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com
How to read the order book for FibroGen Inc.Earnings Overview Report & Advanced Swing Trade Entry Plans - newser.com
Real time breakdown of FibroGen Inc. stock performance2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Risk vs reward if holding onto FibroGen Inc.Market Rally & AI Driven Price Predictions - newser.com
Sentiment analysis tools applied to FibroGen Inc.July 2025 Technicals & High Conviction Buy Zone Alerts - newser.com
Applying Wyckoff theory to FibroGen Inc. stockInflation Watch & Consistent Return Investment Signals - newser.com
Can you recover from losses in FibroGen Inc.Market Growth Summary & Real-Time Volume Analysis - newser.com
Relative strength of FibroGen Inc. in sector analysis2025 Historical Comparison & Verified Short-Term Plans - newser.com
Custom watchlist performance reports with FibroGen Inc.2025 Macro Impact & Verified Momentum Watchlists - newser.com
Real time social sentiment graph for FibroGen Inc.Earnings Beat & Intraday High Probability Alerts - newser.com
Is now a turning point for FibroGen Inc.2025 Price Action Summary & AI Driven Price Forecasts - newser.com
Real time scanner hits for FibroGen Inc. explainedTrade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com
Will FibroGen Inc. (1FG0) stock see valuation expansion2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - newser.com
Long term hold vs stop loss in FibroGen Inc.2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com
Live market analysis of FibroGen Inc.Buy Signal & Expert Approved Momentum Trade Ideas - newser.com
Reversal indicators forming on FibroGen Inc. stockInflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-10-03 05:46:29 - newser.com
What analysts say about FibroGen Inc stockMid Cap Growth Trends & Maximize ROI With Proven Growth Stocks - earlytimes.in
FibroGen Inc Stock Analysis and ForecastEquity Performance Review & High Return Portfolio Growth - earlytimes.in
What drives FibroGen Inc stock priceMonthly Performance Summary & Reap the Rewards of Patience + Planning - earlytimes.in
What analysts say about FibroGen Inc 1FG0 stockBollinger Bands Signals & Exceptional Capital Growth - earlytimes.in
FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress - Investing.com Nigeria
FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress By Investing.com - Investing.com South Africa
William Blair Remains a Hold on FibroGen (FGEN) - The Globe and Mail
H.C. Wainwright Maintains FibroGen(FGEN.US) With Buy Rating, Maintains Target Price $43 - 富途牛牛
FibroGen initiates phase 2 trial of FG-3246 for prostate cancer By Investing.com - Investing.com South Africa
FibroGen initiates phase 2 trial of FG-3246 for prostate cancer - Investing.com India
FGEN: HC Wainwright & Co. Reiterates 'Buy' Rating with $43 Targe - GuruFocus
FibroGen (FGEN) Launches Phase 2 Trial for Antibody-Drug Conjuga - GuruFocus
Finanzdaten der Fibrogen Inc-Aktie (FGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Fibrogen Inc-Aktie (FGEN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wettig Thane | CEO |
Mar 24 '25 |
Buy |
0.35 |
145,000 |
50,663 |
543,329 |
| Schoeneck James A | Director |
Mar 20 '25 |
Buy |
0.35 |
250,000 |
88,000 |
323,722 |
| Schoeneck James A | Director |
Mar 21 '25 |
Buy |
0.34 |
50,000 |
17,040 |
373,722 |
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):